雖然醫學進步讓女性癌症病患有越來越長的存活期,但過去的研究顯示女性癌症病患不孕的風險遠較一般女性為高,其治療所引發的不孕症對適齡生殖的癌症婦女也會帶來嚴重的心理問題與較差的生活品質。目前台灣少子化嚴重,醫治不孕症族群格外重要,現代人工生殖科技發達,使癌症婦女有多樣化的生殖選擇,西醫治療選擇包括卵子冷凍保存、胚胎冷凍保存、卵巢組織冷凍保存、卵巢功能藥物抑制法等,甚至可接受中醫包括辨證施治、中藥週期療法、針灸療法等治療。在國外逐漸推展腫瘤生殖照護的同時,國內推行生殖保護與治療的現況仍不明確,可能存在病患本身、醫療照護提供者與醫療機構等許多障礙因素,未來仍需要跨領域的醫療照護專家共同合作以提供育齡癌症婦女更多的照顧。
Although medical advancements have successfully extended the disease-free survival of female cancer patients, past studies have indicated an increased association between infertility and female patients after cancer-related treatments. These treatments are often associated with severe physiological problems and poor quality of life. Being a country with the lowest birthrate in the world, the issue on the treatment of people with infertility is a very vital problem in Taiwan. A variety of choices are now available for fertility preservation among female patients with cancer. Fertility-preservation treatments of the western medicine include embryo cryopreservation, oocyte cryopreservation, ovarian tissue cryopreservation, ovarian suppression, etc. In addition, the use of Chinese medicine is also a popular alternative, which includes syndrome differentiation and treatment, the Chinese medication by menstrual period, and acupuncture. Although oncofertility care receives considerable attention in many developed countries, little is known about the attitude of female cancer patients towards and provider's practice of fertility treatments in Taiwan. Various patient, physician and provider-related characteristics could have contributed to the barriers to oncofertility care. Physicians with different specializations should therefore cooperate to provide cares that are more appropriate for female cancer patients of child-bearing age.